October 2023 Publications
- Assessing the generation of tissue resident memory T cells by vaccines. Rotrosen E, Kupper TS. Nat Rev Immunol. 2023 Oct. doi: 10.1038/s41577-023-00853-1. Epub 2023 Mar 31.
- Viral-vectored respiratory mucosal vaccine strategies. Jeyanathan M, Afkhami S, Kang A, Xing Z. Curr Opin Immunol. 2023 Oct. doi: 10.1016/j.coi.2023.102370. Epub 2023 Jul 25.
- Using real-life data to model the impact of increasing BCG vaccination coverage and scar prevalence on all-cause infant mortality. Stougaard SW, Benn CS, Aaby P, Nielsen S, Schaltz-Buchholzer F. Ann Epidemiol. 2023 Oct. doi: 10.1016/j.annepidem.2023.07.007. Epub 2023 Jul 20.
- An effective vaccine is only the first step: the need to create and sustain demand for TB vaccines. Nelson KN, Shah NS, Cranmer LM, Vasudevan L, Bednarczyk RA. Int J Tuberc Lung Dis. 2023 Oct 1. doi: 10.5588/ijtld.23.0365.
- Does Early Childhood BCG Vaccination Improve Survival to Midlife in a Population With a Low Tuberculosis Prevalence? Quasi-experimental Evidence on Nonspecific Effects From 32 Swedish Birth Cohorts. Theilmann M, Geldsetzer P, Bärnighausen T, Sudharsanan N. Demography. 2023 Oct 1. doi: 10.1215/00703370-10970757.
- The Mycobacterium tuberculosis genome at 25 years: lessons and lingering questions. Koleske BN, Jacobs WR Jr, Bishai WR. J Clin Invest. 2023 Oct 2. doi: 10.1172/JCI173156.
- Exploring the Potential of Cytomegalovirus-Based Vectors: A Review. Zeng J, Jaijyan DK, Yang S, Pei S, Tang Q, Zhu H. Viruses. 2023 Oct 2. doi: 10.3390/v15102043.
- Use of single-cell technology to improve our understanding of the role of TLR2 in macrophage-Mycobacterium tuberculosis interaction. Gouzy A. mSystems. 2023 Oct 3. doi: 10.1128/msystems.00730-23. Online ahead of print.
- Bacillus Calmette-Guérin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses. DiNardo AR, Arditi M, Kamat AM, Koster KJ, Carrero S, Nishiguchi T, Lebedev M, Benjamin AB, Avalos P, Lozano M, Moule MG, McCune B, Herron B, Ladki M, Sheikh D, Spears M, Herrejon IA, Dodge C, Kumar S, Hutchison RW, Ofili TU, Opperman LA, Bernard JA, Lerner SP, Udeani G, Neal G, Netea MG, Cirillo JD. Trials. 2023 Oct 4. doi: 10.1186/s13063-023-07662-w.
- Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung. Moreo E, Jarit-Cabanillas A, Robles-Vera I, Uranga S, Guerrero C, Gómez AB, Mata-Martínez P, Minute L, Araujo-Voces M, Felgueres MJ, Esteso G, Uranga-Murillo I, Arias M, Pardo J, Martín C, Valés-Gómez M, Del Fresno C, Sancho D, Aguiló N. Nat Commun. 2023 Oct 4. doi: 10.1038/s41467-023-41768-8.
- A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge. Stylianou E, Pinpathomrat N, Sampson O, Richard A, Korompis M, McShane H. Front Immunol. 2023 Oct 5. doi: 10.3389/fimmu.2023.1263457.
- Intravenous Bacille Calmette-Guérin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosis. Larson EC, Ellis-Connell AL, Rodgers MA, Gubernat AK, Gleim JL, Moriarty RV, Balgeman AJ, Ameel CL, Jauro S, Tomko JA, Kracinovsky KB, Maiello P, Borish HJ, White AG, Klein E, Bucsan AN, Darrah PA, Seder RA, Roederer M, Lin PL, Flynn JL, O’Connor SL, Scanga CA. Nat Microbiol. 2023 Oct 9. doi: 10.1038/s41564-023-01503-x. Epub ahead of print.
- Spore-FP1 tuberculosis mucosal vaccine candidate is highly protective in guinea pigs but fails to improve on BCG-conferred protection in non-human primates. White AD, Tran AC, Sibley L, Sarfas C, Morrison AL, Lawrence S, Dennis M, Clark S, Zadi S, Lanni F, Rayner E, Copland A, Hart P, Diogo GR, Paul MJ, Kim M, Gleeson F, Salguero FJ, Singh M, Stehr M, Cutting SM, Basile JI, Rottenberg ME, Williams A, Sharpe SA, Reljic R. Front Immunol. 2023 Oct 10. doi: 10.3389/fimmu.2023.1246826.
- Preliminary evaluation of immunogenicity and protective effect of multicomponent recombinant protein vaccine EPRHP014 against tuberculosis [Chinese]. Cao B, Fan XT, Wang RH, Luan XL, Qian CY, Yu JJ, Liu HC, Li MC, Li GL, Zhao XQ, Yuan XQ, Wan KL. Zhonghua Liu Xing Bing Xue Za Zhi. 2023 Oct 10. doi: 10.3760/cma.j.cn112338-20230217-00088.
- A Glance on Nanovaccine: A Potential Approach for Disease Prevention. Garg A, Chopra H, Singh T, Chaudhary R, Agrawal R, Tankara A. Curr Pharm Biotechnol. 2023 Oct 11. doi: 10.2174/0113892010254221231006100659. Epub ahead of print.
- Comparative pathology of experimental pulmonary tuberculosis in animal models. Hunter L, Ruedas-Torres I, Agulló-Ros I, Rayner E, Salguero FJ. Front Vet Sci. 2023 Oct 12. doi: 10.3389/fvets.2023.1264833.
- Differences in responses to the intracellular macrophage environment between Mycobacterium bovis BCG vaccine strains Moreau and Pasteur. Corrêa PR, Schwarz MGA, Maia RM, Vergara FMF, Moraes MO, Mendonça-Lima L. Mem Inst Oswaldo Cruz. 2023 Oct 13. doi: 10.1590/0074-02760230070.
- Key advances in vaccine development for tuberculosis—success and challenges. Lai R, Ogunsola AF, Rakib T, Behar SM. npj Vaccines. 2023 Oct 13. doi: 10.1038/s41541-023-00750-7
- CD8+ lymphocytes are critical for early control of tuberculosis in macaques. Winchell CG, Nyquist SK, Chao MC, Maiello P, Myers AJ, Hopkins F, Chase M, Gideon HP, Patel KV, Bromley JD, Simonson AW, Floyd-O’Sullivan R, Wadsworth M, Rosenberg JM, Uddin R, Hughes T, Kelly RJ, Griffo J, Tomko J, Klein E, Berger B, Scanga CA, Mattila J, Fortune SM, Shalek AK, Lin PL, Flynn JL. J Exp Med. 2023 Oct 16. doi: 10.1084/jem.20230707. Online ahead of print.
- The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis. Mata-Espinosa D, Lara-Espinosa JV, Barrios-Payán J, Hernández-Pando R. Pharmaceuticals (Basel). 2023 Oct 16. doi: 10.3390/ph16101475.
- IV BCG Vaccination and Aerosol BCG Revaccination Induce Mycobacteria-Responsive γδ T Cells Associated with Protective Efficacy against M. tb Challenge. Morrison AL, Sarfas C, Sibley L, Williams J, Mabbutt A, Dennis MJ, Lawrence S, White AD, Bodman-Smith M, Sharpe SA. Vaccines (Basel). 2023 Oct 17. doi: 10.3390/vaccines11101604.
- Mucosal vaccination: onward and upward. Tsai CJY, Loh JMS, Fujihashi K, Kiyono H. Expert Rev Vaccines. 2023 Jan-Dec. doi: 10.1080/14760584.2023.2268724. Epub 2023 Oct 17.
- Microarray patches: scratching the surface of vaccine delivery. Choo JJY, McMillan CLD, Young PR, Muller DA. Expert Rev Vaccines. 2023 Oct 17. doi: 10.1080/14760584.2023.2270598. Epub ahead of print.
- Global regulatory reforms to promote equitable vaccine access in the next pandemic. Mahoney R, Hotez PJ, Bottazzi ME. PLOS Glob Public Health. 2023 Oct 18. doi: 10.1371/journal.pgph.0002482.
- Construction and evaluation of a novel multi-antigenic Mycobacterium tuberculosis subunit vaccine candidate BfrB-GrpE/DPC. Niu H, Cao Q, Zhang T, Du Y, He P, Jiao L, Wang B, Zhu B, Hu L, Zhang Y. Int Immunopharmacol. 2023 Oct 18. doi: 10.1016/j.intimp.2023.111060. Epub ahead of print.
- Design and Characterization of a Multistage Peptide-Based Vaccine Platform to Target Mycobacterium tuberculosis Infection. Bellini C, Vergara E, Bencs F, Fodor K, Bősze S, Krivić D, Bacsa B, Surguta SE, Tóvári J, Reljic R, Horváti K. Bioconjug Chem. 2023 Oct 18. doi: 10.1021/acs.bioconjchem.3c00273. Epub 2023 Aug 22.
- Nano-Sized Chimeric Human Papillomavirus-16 L1 Virus-like Particles Displaying Mycobacterium tuberculosis Antigen Ag85B Enhance Ag85B-Specific Immune Responses in Female C57BL/c Mice. Zhou F, Zhang D. Viruses. 2023 Oct 19. doi: 10.3390/v15102123.
- Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells. Singh AK, Wang R, Lombardo KA, Praharaj M, Bullen CK, Um P, Gupta M, Srikrishna G, Davis S, Komm O, Illei PB, Ordonez AA, Bahr M, Huang J, Gupta A, Psoter KJ, Creisher PS, Li M, Pekosz A, Klein SL, Jain SK, Bivalacqua TJ, Yegnasubramanian S, Bishai WR. iScience. 2023 Aug 24. doi: 10.1016/j.isci.2023.107733. eCollection 2023 Oct 20.
- Conference report: WHO meeting report on mRNA-based tuberculosis vaccine development. Looney MM, Hatherill M, Musvosvi M, Flynn J, Kagina BM, Frick M, Kafuko Z, Schmidt A, Southern J, Wilder-Smith A, Tippoo P, Paradkar V, Popadić D, Scriba TJ, Hanekom W, Giersing B. Vaccine. 2023 Oct 21. doi: 10.1016/j.vaccine.2023.10.026. Epub ahead of print.
- Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan. Liu Y, Chen T, Zhu Y, Furey A, Lowary TL, Chan J, Bournazos S, Ravetch JV, Achkar JM. JCI Insight. 2023 Oct 23. doi: 10.1172/jci.insight.167960.
- Development of multi-epitope based subunit vaccine against Mycobacterium Tuberculosis using immunoinformatics approach. Kumari R S, Sethi G, Krishna R. J Biomol Struct Dyn. 2023 Oct 25. doi: 10.1080/07391102.2023.2270065. Epub ahead of print.
- Vaccination with mycobacterial lipid loaded nanoparticle leads to lipid antigen persistence and memory differentiation of antigen-specific T cells. Morgun E, Zhu J, Almunif S, Bobbala S, Aguilar MS, Wang J, Conner K, Cui Y, Cao L, Seshadri C, Scott EA, Wang CR. Elife. 2023 Oct 25. doi: 10.7554/eLife.87431.
- Preparation of Mycobacterium tuberculosis EsxV lipid nanoparticles subunit vaccine and its immunological characteristics. [Chinese]. Bai L, Lu Y, Ning H, Kang Y, Xie Y, Kang J, Li X, Cui R, Wei Y, Liu Y, Bai Y. Sheng Wu Gong Cheng Xue Bao. 2023 Oct 25. doi: 10.13345/j.cjb.230245.
- Correspondence Regarding: McShane H. Improving TB vaccine trial efficiency: A tough nut to crack. Hill PC, Cobelens F, Martinez L, Garcia-Basteiro A, Behr M, Rangaka MX, Churchyard G, Evans T, Hanekom W, White R. J Infect Dis. 2023. J Infect Dis. 2023 Oct 28. doi: 10.1093/infdis/jiad466. Epub ahead of print.
- Helper T cell bias following tuberculosis chemotherapy identifies opportunities for therapeutic vaccination to prevent relapse. Martinez-Martinez YB, Huante MB, Chauhan S, Naqvi KF, Bharaj P, Endsley JJ. NPJ Vaccines. 2023 Oct 28. doi: 10.1038/s41541-023-00761-4.
- Phosphatidylinositolmannoside vaccination induces lipid-specific Th1-responses and partially protects guinea pigs from Mycobacterium tuberculosis challenge. Eckhardt E, Schinköthe J, Gischke M, Sehl-Ewert J, Corleis B, Dorhoi A, Teifke J, Albrecht D, Geluk A, Gilleron M, Bastian M. Sci Rep. 2023 Oct 30. doi: 10.1038/s41598-023-45898-3.
- Tuberculosis prevention: current strategies and future directions. Vasiliu A, Martinez L, Gupta RK, Hamada Y, Ness T, Kay A, Bonnet M, Sester M, Kaufmann SHE, Lange C, Mandalakas AM. Clin Microbiol Infect. 2023 Oct 31. doi: 10.1016/j.cmi.2023.10.023. Epub ahead of print.